Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod after Curettage and Cautery for Facial Nodular BCC
NCT00463359Phase 2Unknown
- Sponsor
- University of Glasgow
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of imiquimod in basal cell carcinoma (BCC), sponsored by University of Glasgow. Status: unknown.
02
Drugs
imiquimod
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT00463359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00463359.